Institutional investors hold a majority ownership of NBIX through the 97.73% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $2.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ORBIMED ADVISORS LLC Bought 1.1 Million shares of Neurocrine Biosciences In...